Biotech | October 09, 2021
Cyprium Therapeutics and Sentynl, a Zydus subsidiary announce positive data for CUTX-101, CuHis
The rolling submission to the U.S. FDA will begin in the fourth quarter of this year
The rolling submission to the U.S. FDA will begin in the fourth quarter of this year
Alnylam is the latest partner in the Medicines Manufacturing Innovation Centre’s third Grand Challenge project, which aims to revolutionise the manufacturing process for oligonucleotide therapies
This opens up a huge market for the company’s Magnezis implants in India
Early-stage research suggests the potential to prevent and treat all dengue serotypes and builds on Johnson & Johnson's work to advance science against emerging and entrenched global public health threats
The company will use the capital for building its team, product development, marketing, and setting up in-school clinics to deliver connected health to one million families
The transaction is anticipated to close in the first quarter of 2022
FUJIFILM will distribute iSWAB bio sampling technologies in Japan
More than 90,000 patients utilise the services daily
The state-of-the-art facility provides a pathway from development to large-scale biologics production
The 462,000 square foot state-of-the-art building targeting LEED Zero certification and is designed to be the most sustainable commercial lab building in Cambridge
Subscribe To Our Newsletter & Stay Updated
